Title: DynamicLate Activation Mapping in Heavily Scarred Left Atrium andPersistent Atrial Fibrillation; A Proof of Concept Case Report
Credits: Benjamin Mac Curtain, James Mannion, Santhosh David, Roger Byrne, Usama Boles
Title: Contemporary Yield of 24-hour Holter Monitoring: Role of Inter-Atrial Block Recognition
Title: Anticoagulation and Clinical Outcomes in Heart Failure Patients With Atrial Fibrillation: Findings From the ADHERE Registry
Credits: Zubin J. Eapen, MD, Xiaojuan Mi, PhD, Gregg C. Fonarow, MD, Soko Setoguchi, MD, DrPH, Jonathan P. Piccini, MD, MHS, Roger M. Mills, MD, Winslow Klaskala, PhD, MS, Lesley H. Curtis, PhD, Adrian F. Hernandez, MD, MHS.
Affiliation: Dr. Raffaele Corbisiero is the Chair of Pacing and Electrophysiology and Director of the Electromechanical Therapy Institute at Deborah Heart and Lung Center in Browns Mills NJ. He received specialty training in interventional cardiology at New York Medical College, and Electrophysiology training at Baystate Medical Center, western campus of Tufts. His research efforts include implantable defibrillators, cardiac resynchronization, and pacemakers and has published in multiple journals. He recently participated on an international panel on heart failure and CRT therapy.
Affiliation: Dr. Raffaele Corbisiero is the Chair of Pacing and Electrophysiology and Director of the Electromechanical Therapy Institute at Deborah Heart and Lung Center in Browns Mills NJ. He received specialty training in interventional cardiology at New York Medical College, and Electrophysiology training at Baystate Medical Center, western campus of Tufts. His research efforts include implantable defibrillators, cardiac resynchronization, and pacemakers and has published in multiple journals. He recently participated on an international panel on heart failure and CRT therapy
Affiliation: Director of Electrophysiology at Sequoia Hospital, Redwood City California and founder of Silicon Valley Cardiology, E. Palo Alto California. He was trained as an electrical engineer. His early interests were in the clinical pharmacology of antiarrhythmic drugs and ambulatory ECG monitoring. He subsequently helped refine the implantable defibrillator to make it a clinically viable option by developing the first tiered-therapy defibrillator and he introduced defibrillation threshold testing, the transvenous defibrillation lead and the biphasic defibrillation waveform. He has founded several companies in Silicon Valley. Current research interests include improving the safety and efficacy of atrial fibrillation ablation and anticoagulation in the peri-ablation period.
ISLAA 2022-Left Atrial Appendage
Dr. Dhanunjay Lakkireddy, MD, F.A.C.C, FHRS, The Kansas City Heart Rhythm Institute (KCHRI), KS, USA.
Display Ads on JAFIB to reach Users world wide...
Suggest an Event to get good mileage from Users World wide...